Although it abandoned its own efforts to develop a coronavirus vaccine and instead is helping Johnson & Johnson produce theirs, New Jersey-based drugmaker Merck is testing therapeutics and medications to treat the disease.

The pharmaceutical company says it has developed a potential breakthrough drug, shown to quickly reduce infection. Senior Correspondent Brenda Flanagan reports.

WATCH: How NJ hospitals are dealing with COVID-19 one year later

MORE: COVID-19: Why it could affect public health for years to come